In this video, Stephen M. Ansell, MD, PhD professor of medicine, chair of the division of hematology, co-leader of the hematological malignancies program, and interim chair of the department of ...

Acquired miR-142 deficit in leukemic stem cells has been associated with chronic myeloid leukemia blast crisis. Here the authors show that acquired miR-142 deficit in T cells further enables ...

This useful study presents a genetically encoded barcoding system that could advance transcriptomic studies and that has the potential for further applications, such as in high-throughput ...

Neoplastic cell morphology in peripheral blood (A) and bone marrow aspirate films (B) showing small- to medium-sized lymphoplasmacytic lymphocytes (May Grunwald Giemsa stain, 1000×). Bone marrow ...

Fluorescence-activated cell sorting was performed on an FACSAria III Cell Sorter (BD Biosciences). All flow cytometry data were analyzed using the FlowJo software (Tree Star, Ashland, OR). Equal ...

Each category includes or excludes specific kinds of money. There was yet another number, M3, but its reporting was discontinued by the Fed in 2006. There are also M0 and MB, but these are ...

a AML = acute myelogenous leukemia. b Percentages do not total 100 because of rounding. c Significantly different from the corresponding value for the gemtuzumab ozogamicin group (p < 0.001).

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

Expert Rev Hematol. 2012;5(4):395-407. AML: Acute myeloid leukemia; APL: Acute promyelocytic leukemia; CBF: Core-binding factor; CEBPA-DM: CCAAT enhancer-binding protein-α with double mutation ...